Minovi Amir, Basten Oliver, Hunter Ben, Draf Wolfgang, Bockmühl Ulrike
Department of Otorhinolaryngology, Head and Neck and Facial Plastic Surgery, Klinikum Fulda gAG, Teaching Hospital of the Philipps-University Marburg, Pacelliallee 4, 36043 Fulda, Germany.
Head Neck. 2007 May;29(5):439-45. doi: 10.1002/hed.20537.
This study analyzes the management and outcomes of a series of 10 malignant peripheral nerve sheath tumors (MPNST) of the head and neck.
From 1984 to 2004, 10 patients underwent surgical treatment of a MPNST. We retrospectively reviewed presenting symptoms, radiological findings, surgical management, and follow-up status and performed a literature review.
Eight tumors were located at the lateral skull base; 2 involved the vagus nerve in isolation. Two lesions were growing within the sinonasal tract. The most common presenting symptom was a rapidly enlarging cervical mass. Seventy percent of the tumors could be resected completely. Long-term follow-up showed a 2-year disease-specific survival rate of 50% and 5-year survival rate of 20%. Negative prognostic indicators were advanced tumor stage, early recurrence, and presumably also the presence of von Recklinghausen's disease. Postoperative adjuvant radiotherapy was found to make no difference in outcome.
Although rare, MPNST is one of the most aggressive tumors in the head and neck area. Complete tumor removal is the mainstay of treatment and most important prognostic factor of MPNST. Adjuvant radiotherapy should be used to assist surgical excision in local control. The role of adjuvant chemotherapy remains controversial.
本研究分析了一系列10例头颈部恶性外周神经鞘瘤(MPNST)的治疗及预后情况。
1984年至2004年期间,10例患者接受了MPNST的手术治疗。我们回顾性分析了患者的症状、影像学表现、手术治疗情况及随访状态,并进行了文献复习。
8例肿瘤位于侧颅底;2例仅累及迷走神经。2例病变位于鼻窦道内。最常见的症状是颈部肿块迅速增大。70%的肿瘤能够完全切除。长期随访显示,疾病特异性2年生存率为50%,5年生存率为20%。预后不良指标包括肿瘤分期较晚、早期复发,推测还包括存在冯雷克林霍增氏病。发现术后辅助放疗对预后无影响。
尽管MPNST罕见,但它是头颈部最具侵袭性的肿瘤之一。完整切除肿瘤是MPNST治疗的主要手段及最重要的预后因素。辅助放疗应用于协助手术切除以实现局部控制。辅助化疗的作用仍存在争议。